Tue, 21-Oct-2025

Watch Live

logo-black

Download App

Watch Live

china

Philippines to priorities economic assistance over security

by
Philippines
  • China and the Philippines signed 14 bilateral treaties in the fields of industry, agriculture, and tourism.
  • China’s exports to the Philippines increased at a 20% annual rate.
  • The Philippines hopes that Chinese investments will help fund its “Build Build Build” program.

Philippines President Ferdinand Marcos Jr. returned home from a three-day visit to China with $22.8 billion in trade and investment deals. It was in keeping with his promise before leaving for Beijing to return “with a harvest of agreements and investments” to strengthen the Philippines’ economic foundations.

Marcos inherited a strong relationship with China from his late father, President Ferdinand Marcos Sr., who was one of the first US allies to abandon Taipei for Beijing in 1976. The junior had gone to China with his father and met Chairman Mao Zedong. Marcos Jr. recalled the trip, saying he “watched the development of our bilateral ties with great interest and attention.” The current visit, according to him, is intended to “continue that legacy of strengthening the bonds of friendship established between the Filipino and Chinese peoples.”

During his presidential campaign, Marcos openly supported President Rodrigo Duterte’s foreign policy, referring to China as the Philippines’ “strongest partner” and “emphasizing the futility of confrontation and the value of robust economic cooperation with the Asian powerhouse.” Marcos, like Duterte, chose China for his first major overseas trip. Their predecessors had either visited Washington or Tokyo first.

China and the Philippines signed 14 bilateral treaties in the fields of industry, agriculture, and tourism. Investment and funding arrangements for projects undertaken with Chinese assistance are among the other agreements.

How China became the Philippines’ largest trading partner

In recent years, trade between the two countries has thrived. From 2010 to 2017, China’s exports to the Philippines increased at a 20% annual rate, allowing China to surpass Japan as the Philippines’ largest trading partner in 2016. China will be the Philippines’ second-largest export market by 2021. China is also said to have committed to reducing the trade deficit, which is currently in China’s favor, by increasing imports from the Philippines.

Duterte’s election in 2016 improved relations with China, and his visit to Beijing that year resulted in $24 billion in investment and credit line pledges. President Marcos undertook the China trip early in his term to “shift relations into a higher gear”. The Philippines hopes that Chinese investments will help fund its “Build Build Build” program, which aims to improve domestic infrastructure, which is critical for economic growth.

Though Duterte’s presidency was described as a “golden era” in the Philippines, tensions with China emerged near the end of his presidency, when Beijing barred resupply missions to Philippines-owned islands in the South China Sea. Such encounters put his successor, Ferdinand Marcos Jr., under pressure from the military and the public to take a more assertive stance on the South China Sea territorial claims.

Despite Marcos’ promising start, the Philippines’ relations with China may be tested over a number of issues, including inadequate development of major infrastructure projects, disputed claims over the South China Sea, and the nature and extent of Manila’s defence ties with Washington. China is understandably concerned about America’s military presence in its backyard.

The Philippines is in the difficult position of having the most contested claims in the South China Sea with China. To China’s detriment, the Hague arbitration tribunal recognized the Philippines’ claims. Duterte put the ruling on hold in order to benefit from China’s economic relations.

The two sides have attempted to settle their differences several times with little success. Though China prefers individual negotiations with each disputing party, the ten-nation Association of Southeast Asian Nations (ASEAN), of which the Philippines is a member, has steadfastly negotiated these claims as a group.

Manila’s relations with the United States

In contrast to his predecessor, Marcos Jr. is warming up to the United States. China is keeping a close eye on things. Early in his presidency, US Vice President Kamala Harris and Secretary of State Antony Blinken were among the first visitors. The Philippines understands that a US military alliance can provide deterrence to China, but the US lacks the courage or capacity to provide economic support to raise people’s living standards. Raising military stakes at the expense of economic development will harm the Philippines’ chances of revival, as it has done for many other countries. China will closely monitor the proposed defense ties and will withdraw investments if Marcos Jr. is seen to have an unfavorable impact on Chinese interests.

Marcos is well aware that the US has fallen short of expectations on important economic needs of developing countries, and that much of its engagement is limited to military security. Under the guise of ‘freedom of navigation,’ the US has significantly increased its military presence in the region.

According to current trends, the Philippines will continue to pursue a strong economic partnership with China in order to lift people out of poverty.

[embedpost slug=”/philippines-maria-ressa-was-found-not-guilty-of-tax-evasion/”]

Read more

People are left hanging upside down in Chinese amusement park

by
amusement park

An unsettling video of passengers hanging upside-down on a malfunctioning ride. The incident took place in Fuyang. For ten minutes, tourists were left hanging. Tourists were left dangling upside-down on a malfunctioning amusement park ride in a horrifying event in China. There is a violent video of the same thing making the rounds on the … Read more

Pakistan’s bilateral trade with China to reach new heights: Bilawal

by
Bilawal

Bilawal said bilateral trade relationship with China is expected to flourish He said Pakistan-China relations have also grown due to CPEC Trade relations with China have exceeded pre-pandemic levels DAVOS: Foreign Minister Bilawal Bhutto Zardari said that the bilateral trade relationship with China is expected to flourish further due to the cooperation between both countries … Read more

Bolivia chooses Chinese company Catl to help develop lithium deposit

by
Catl
  • Chinese company Catl, won the bidding process to develop lithium reserves.
  • Bolivia has enormous reserves in the Potosi and Oruro salt flats.
  • Argentina, Bolivia, and Chile share a stretch of salt that contains more than 75% of the world’s lithium deposits.

Catl, a massive Chinese battery company, has won a bidding process to develop Bolivia‘s massive lithium reserves.

The ultra-light metal is used in EV batteries, the production of which is expected to skyrocket as fossil fuels are phased out.

Bolivian President Luis Arce stated that the Catl-led consortium was launching the “historic” industrialization of lithium in Bolivia.

The first phase of the project will cost more than $1 billion (£807 million), according to him.

The world’s largest lithium producers are Australia and Chile, but Bolivia has enormous reserves in the Potosi and Oruro salt flats.

Technical challenges and a lack of infrastructure have long stymied lithium extraction in Bolivia, where reserves are estimated to be 21 million tonnes.

Mr. Arce stated that Bolivia was still in talks with other foreign companies about potential partnerships. According to sources, they include the US firm Lilac Solutions, Russia’s Uranium One Group, and three other Chinese bidders.

Mr. Arce stated that the company’s goal was to begin exporting lithium batteries in the first quarter of 2025.

Argentina, Bolivia, and Chile share a stretch of salt flats known as the “lithium triangle,” which contains more than 75% of the world’s lithium deposits.

Brine is pumped from beneath the salt flats into vast evaporation pools, resulting in the formation of lithium carbonate. However, the technical challenges of lithium mining have raised concerns in South America and other parts of the world about pollution and commercial viability.

[embedpost slug=”/santa-cruz-governor-luis-camacho-to-remain-detained-ahead-of-trail-bolivian-judge/”]

Read more

Chinese jump into traditional remedies to fight COVID-19

by
COVID-19
  • Ever since the pandemic began, President Xi has pushed TCM.
  • According to critics, it is inefficient for treating true sickness.
  • China has millions of users who frequently combine it with Western medicine.

BEIJING: As COVID-19 rips through China’s vast population, making millions sick and fuelling a shortage of drugs, many are turning to old-school traditional medicines to battle the aches and pains of the virus.

President Xi Jinping has promoted traditional Chinese medicine (TCM) since the start of the pandemic, while health officials have hailed its “important role” in fighting the coronavirus.

Encompassing a range of treatments from herbal remedies and massages to acupuncture and diets, TCM has been used for thousands of years to treat all manner of ailments.

Critics say it is pseudoscientific and ineffective in treating actual illness, and there is little peer-reviewed data to back claims of its efficacy.

But millions in China use it, often in conjunction with modern medicine to alleviate symptoms.

Beijing consultant Yu Lei, 38, had a fever after catching COVID, so he made a herbal tea with reputed anti-inflammatory properties featuring cassia twig — a kind of Chinese cinnamon — peony roots, liquorice, jujubes and ginger.

“In our family, we often use Chinese medicines,” he told AFP, adding that his fever subsided after drinking the brew.

According to followers like Yu, TCMs have fewer side effects and work slower to regulate the body, rather than Western medicines that “fight the symptoms but rarely the source of the illness”.

Beijing has urged local authorities to “actively and objectively publicise the role and efficacy of TCM brews in the treatment of COVID-19“.

However, Ben Cowling, chair of epidemiology at the University of Hong Kong’s School of Public Health, told AFP: “We don’t know whether these treatments are effective or not, because they haven’t been studied in clinical trials.”

“I wouldn’t rule out the possibility that some of them are effective, but I also wouldn’t rule out the possibility that some of them might even be harmful.”

The World Health Organisation only recommends COVID treatments that are based on chemical drugs. When contacted by AFP about TCM, the body said it advised countries to “gather reliable evidence and data on traditional medicine practices and products”.

‘Same logic’

Western medicine remains the preferred mode of care in China, but proponents of TCM say combining the two is effective in treating COVID-19.

Liu Qingquan, director of the Beijing Traditional Chinese Medicine Hospital, says they “complement each other and can solve fever, sore joints, fatigue, sore throat, cough and other symptoms”.

Experts have taken to television to praise TCM since the start of the pandemic, with one product in particular — Lianhua Qingwen — benefiting from intense promotion by authorities.

Many users are convinced of its usefulness, with some studies suggesting it can help alleviate symptoms. Capsules of the medicine were given to all Hong Kong residents when a COVID wave hit the city last year.

But some online critics in China charge that Lianhua Qingwen is no more effective than peaches in syrup — a staple comfort food for sore throats in China — and social media users have complained of being handed the TCM instead of ibuprofen or paracetamol.

Lan Jirui, a doctor of Chinese medicine in Beijing, told AFP: “It’s the same logic as Western medicine.

“If the drug is bought on the prescription of the doctor, it will probably be effective. If it is bought randomly from the pharmacy, then maybe not.”

‘Cannot kill the virus’

Throughout the pandemic, TCM doctors and self-taught practitioners have taken to the internet to share recipes and health protocols.

Li Wen, a 68-year-old retired acupuncturist, has been pricking himself with needles to combat his flu-like condition. He also bought two Chinese medicines, including a bamboo-based anti-fever remedy.

“I supplement that with a nutritious diet of pears, turnips and ginger,” he told AFP.

“Chinese medicines can be helpful to fight the virus, but cannot kill the virus,” he said.

“But I remain cautious about Western drugs. Their side effects should not be overlooked.”

Hoping to treat a cough and sore throat, Danni, a 39-year-old Beijinger, has been taking Pei Pa Koa, a syrup derived from plant extracts.

“It’s not because I can’t find Western medicine,” she told AFP, “but because it’s effective and soothing.”

“I also make myself a hot soup of pears and hot water with lemon, to boost vitamin C and my immunity.”

Some people AFP spoke to were unconvinced.

“We young people know little about traditional medicine,” said Grace Hsia, a 30-year-old director. “We usually prefer Western medicines because they have immediate results.”

Li Na, a 36-year-old Beijing woman, said: “I took paracetamol for a fever and it worked very quickly.

“Chinese medicines are ineffective. People take them more to reassure themselves that they are taking something.”

[embedpost slug=”china-as-holiday-travel-increases-critical-covid-cases-have-peaked/”]

Read more

China: As holiday travel increases, critical COVID cases have peaked

by
COVID
  • Millions travel across the country for Lunar New Year
  • 60,000 people with COVID died in hospitals
  • Daily deaths could hit 36,000 next week.

The number of COVID patients requiring critical care in Chinese hospitals has peaked, according to health officials, as millions travel across the country for long-awaited family reunions, raising fears of new outbreaks.

Since abruptly removing anti-virus controls that had protected China‘s 1.4 billion people from the disease for three years last month, there has been widespread skepticism about China’s official COVID data.

China revealed on Saturday that nearly 60,000 people with COVID died in hospitals between December 8 and January 12, a tenfold increase from previous disclosures.

However, that figure excludes those who die at home, and some Chinese doctors have stated that they are discouraged from including COVID on death certificates.

According to the latest forecasts from UK-based health data firm Airfinity, as travel increases during the busy Lunar New Year holiday season, up to 36,000 people could die from the disease each day. Other experts predict that more than a million people will die from the disease this year.

However, a National Health Commission official stated at a press conference on Thursday that China has passed the peak period for COVID patients in fever clinics, emergency rooms, and in critical condition.

According to an official, the number of patients in critical condition in hospitals was more than 40% lower on Jan. 17 than at the peak on Jan. 5.

The new data comes after President Xi Jinping expressed concern that rural areas would be unprepared to deal with an increase in infections as the holidays, which begin on January 21, bring throngs of city dwellers back to their hometowns.

Essential Burden

Affinity estimated on Wednesday that 62 million people could be infected with the virus between January 13 and January 27 and that COVID-related daily deaths could peak at 36,000 on January 26, a significant increase from previous estimates.

“Our forecast predicts a significant burden on China’s healthcare system over the next two weeks, and it is likely that many treatable patients will die as a result of overcrowded hospitals and a lack of care,” said Airfinity’s analytics director Matt Linley.

Beyond the death toll, there is hope that China’s reopening will reenergize a $17 trillion economy that is experiencing one of its lowest growth rates in nearly a half-century.

After years of virus restrictions and a recent wave of infections disrupted business, owners and managers of China’s factories, which produce nearly a third of the world’s manufactured goods, hope to return to normalcy.

The IMF’s Deputy Managing Director Gita Gopinath said on Wednesday at the World Economic Forum in Davos that China could see a sharp recovery beginning in the second quarter.

These expectations have propelled China’s stock markets and the yuan currency to multi-month highs in recent sessions.

Chinese-controlled Hong Kong, which is attempting to revitalize its finance and trade-dependent economy, announced on Thursday that people infected with COVID-19 will not be required to quarantine beginning January 30, removing one of the city’s last major virus restrictions.

[embedpost slug=”/chinas-population-has-declined-for-the-first-time-in-60-years/”]

Read more

Taiwan allows women into military reserve force training

by
Taiwan allows women into military

220 female reservists who have been released will be able to join in training. Taiwan maintains a military force of roughly 170,000 people. The majority of whom are volunteers and train 120,000 reservists yearly. Taiwan’s military on Tuesday unveiled plans to enable women to volunteer for reserve force training for the first time, as China … Read more

Experts warning to the US Navy, larger fleets always wins

by
US Navy

US Naval War College professor has a warning for American military planners. As China continues to expand what is already the greatest navy in the world. Former US Navy Captain and Leidos Chair of Future Warfare Studies, Tangredi examined 28 maritime warfare. A professor at the US Naval War College has a warning for American … Read more

China’s population has declined for the first time in 60 years

by
China

The population decreased by 850,000 from 2021 to 2022, reaching 1.4118 billion. For the first time ever, deaths also exceeded births in China last year. Chinese President Xi Jinping called increasing birth rates a top priority in October 2022. China’s population has decreased for the first time in 60 years with a record-low national birth … Read more

Indonesian nickel smelter begins operations following a deadly riot

by
Nickel
  • Activities were being put on hold due to violence and protests that left two workers dead.
  • Due to the conflicts between demonstrators, employees, and security personnel.
  • More than 500 police and military personnel were deployed.

Police said that activities at a Jiangsu Delong Nickel Industry-owned nickel smelter in Indonesia have resumed after being put on hold due to violence and protests that left two workers dead over the weekend.

Conflicts between demonstrators, employees, and security personnel took place at the PT Gunbuster Nickel Industry (GNI) smelter, a division of Jiangsu Delong, and resulted in the deaths of an Indonesian and a Chinese worker, as well as the burning of vehicles and dorms.

The Central Sulawesi police spokeswoman Didik Supranoto said in a statement on Tuesday that “the situation at GNI in North Morowali is somewhat favorable and the firm today has commenced operating.”

“Hundreds of personnel have arrived at the site,” he continued, posting a video of workers arriving on motorcycles while police officers stood guard at the facility’s entrance. The workers were wearing grey uniforms and yellow helmets.

GNI was not available for comment. It stated in a statement on Monday that it is collaborating with the police to look into what sparked the incidents.

Indonesia’s police chief on Monday said more than 500 police and military personnel have been deployed to secure the nickel smelting facility, and more would reinforce.

The Chinese embassy in Jakarta condemned the violence.

“We, as the Indonesian Government did, condemn this vile incident, during which the violent breaking into the industrial park caused casualties of Chinese and Indonesian staff and damage of facilities in the park,” the embassy said in a statement.

[embedpost slug=”/indonesia-6-2magnitude-earthquake-strikes-off-the-coast/”]

Read more

China’s 2022 Economic Growth Slows Due to Coronavirus Restrictions

by
China

Beijing abruptly changed its tight zero-Covid stance last month. The world’s second-largest economy’s GDP increased by 3% in 2022. Although far lower than the government’s 5.5% target. The second-slowest rate of economic growth in China’s history was recorded last year, a sign of the negative impact the nation’s stringent coronavirus laws have had on the … Read more

China’s population declines for the first time since 1961

by
China

The population in 2022 will be 1.4118 billion, down 850,000 from 2021. Deaths also exceeded births for the first time last year. For the first time in 60 years, China’s population has declined. For the first time in 60 years, China’s population has declined, with the national birth rate reaching a record low of 6.77 … Read more

China approves GM alfalfa import for first time in decade

by
gmo alfalfa

China allows the import of eight genetically modified crops. China permits the import of GM crops used as animal feed. China approves three genetically modified crops. According to the country’s agriculture ministry, China has allowed the import of eight genetically modified (GM) crops, allowing exports of GM alfalfa for the first time in ten years. … Read more

Japan, US and Europe must act together on China, says Kishida

by
Kishida

Fumio Kishida spoke at Johns Hopkins School of Advanced International Studies. Japan this month declared its largest military build-up since World War II. Biden commended Tokyo’s “historic” defense build up. During a visit to strengthen Tokyo’s alliance with the US in the face of mounting challenges from Beijing, Japanese Prime Minister Fumio Kishida stated in … Read more

China reports almost 60,000 Covid-related deaths in 1 month

by
China

China reports 54,435 overall COVID-related deaths from December 8 through Thursday. More than 90% of those who passed away had cancer, heart, lung, or kidney issues. China abruptly lifted anti-virus regulations in December and stopped releasing data. China has responded to allegations that it was withholding statistics by reporting roughly 60,000 deaths among Covid victims, … Read more

Indonesia sends a warship to monitor China coast guard vessel

by
Indonesia
  • Indonesia  sent a warship to the North Natuna Sea.
  • The Chinese ship CCG 5901 has been traveling in the Natuna Sea
  • Both nations claim resource-rich maritime territory as their own.

According to the commander of the country’s navy, Indonesia has sent a warship to the North Natuna Sea to keep an eye on a Chinese coast guard boat that has been operating in a resource-rich maritime territory both nations claim as their own.

Laksamana Madya Muhammad Ali, the head of the Indonesian navy, told the sources on Saturday that a warship, a marine patrol plane, and a drone had been sent out to watch the Chinese vessel.

“The Chinese vessel has not conducted any suspicious activities. However, we need to monitor it as it has been in Indonesia’s exclusive economic zone (EEZ) for some time,” he added.

Since December 30, the Chinese ship CCG 5901 has been traveling in the Natuna Sea, notably close to the gas fields in Vietnam’s Chim Sao oil and gas field and Indonesia’s Tuna Block, according to ship tracking data, the Indonesian Ocean Justice Initiative told Reuters.

The largest coast guard ship in the world, the CCG 5901 from China, is known as “the monster” because of its size. Vessels are granted navigation rights through an EEZ under the United Nations Convention on the Law of the Sea (UNCLOS).

Vietnam and Indonesia

Vietnam and Indonesia recently approved a development plan for the Tuna gas field, involving an estimated investment of more than $3bn to commence production. But the presence of a Chinese vessel in their exclusive economic zone (EEZ) may signal increasing Chinese assertiveness in the area.

In 2021, vessels from Indonesia and China kept an eye on one another for several months as they were in close proximity to a submersible oil rig that was conducting tests in Indonesia’s gas-field development area. China demanded that Indonesia stop the test drilling at the time, saying that the operations were occurring on its soil.

Indonesia and China are locked in a row over maritime territorial claims in the South China Sea. Indonesia maintains that under UNCLOS, the southern end of its exclusive economic zone – since renamed North Natuna Sea – is its exclusive maritime zone. It is part of a push back against China’s maritime territorial ambitions in the area.

China asserts that the oceanic space off the coast of Indonesia is under its vast territorial claim in the South China Sea, which is delineated by a “nine-dash line” in the shape of a U. In 2016, the Permanent Court of Arbitration in The Hague determined that the nine-dash line lacked a legitimate foundation.

A spokesperson for the Chinese embassy in Jakarta was not immediately available for comment.

[embedpost slug=”/joko-widodo-admits-indonesias-past-human-rights-violations/”]

Read more

Indonesia assigns warship to keep tabs on Chinese coast guard vessel

by
warships

Indonesia has deployed a warship to the North Natuna Sea. Warship will monitor any activity of Chinese coast guard vessel. Vessels from Indonesia and China trailed each other for months. According to the country’s naval chief, Indonesia has deployed a warship to the North Natuna Sea to monitor a Chinese coast guard vessel that has … Read more

Covid drug shortage in china increases frustration

by
Drug
  • The price demanded is too high.
  • Many people have turned to the black market.
  • Pfizer declined to comment on the price it had proposed.

Hong Kong- The government’s failure to negotiate an agreement with prized drug Pfizer to include Paxlovid in its national insurance plan was aggravated by a revelation Sunday that the price demanded was too high, according to officials. This decision may imply that after March 31, the drug will only be available to individuals who can afford to pay full price, which is currently roughly 1,900 yuan ($280) for each course.

Many people have turned to the black market in recent weeks, where hawkers claim to provide Covid medicines ranging from illegal imports of Indian-made generics of Pfizer’s Paxlovid and Merck’s molnupiravir to the genuine substance – at up to nearly eight times the market price.

When taken promptly after the onset of symptoms, Paxlovid has been found to lower the risk of death and hospitalization in high-risk patients. The medicine, which is commonly used in industrialized countries, was approved as the first oral pill particularly for Covid in China in February.

The traditional Chinese remedy Qingfei Paidu and the domestic antiviral drug Azvudine were two more treatments utilized for Covid-19 that China did agree to pay in the most recent negotiations. Data on Azvudine’s effectiveness in preventing serious illness are scarce.

Prized drug

Currently, Pfizer’s imported pill is available in community hospitals in some cities, including Beijing, Shanghai, Tianjin, and Guangzhou.

It is also supplied on a number of e-commerce sites, where some local news reports indicate that supply issues are beginning to ease.

However, there are questions about how broadly the pills will be distributed across China.

This is a critical issue as the epidemic spreads from major cities to smaller ones and rural China. According to experts, procurement appears to be decentralized, with the pills being easier to locate at hospitals in major cities with more resources and harder to find elsewhere.

Statement from CEO

Albert Bourla, the CEO of Pfizer, stated on Monday that the business had increased exports, sending millions of courses of Paxlovid to China in the previous few weeks and that it was collaborating with its domestic partner Zhejiang Huahai to produce Paxlovid in China in the first half of this year.

But Bourla also dispelled hopes that the business may strike a deal with China for domestic drugmakers to create a generic version of the medication to be sold domestically when addressing at a conference in San Francisco.

Merck announced on its WeChat account that it will pursue legal action against some producers who were selling counterfeit versions of its Covid medication. The company will also collaborate with regional business Sinopharm to export its pill, Lagevrio, to China.

However, as the current shortages – and cost concerns – play out in one of the main countries producing generic drugs, they also shine a light on international challenges relating to intellectual property rights, according to specialists who look at access to medications.

The WHO-affiliated Medicines Patent Pool (MPP) reports that two Chinese firms have submitted their goods for review by the WHO. Zhejiang Huahai and Apeloa Pharmaceutical, along with two others in China, were granted sublicenses to produce the full generic pill in 2022.

Such flexibilities have the potential to irk foreign pharmaceutical companies and the countries where they are based, experts say. China’s concerns about impacting the local economy were likely a key reason for its reticence to use such measures.

Beijing this month called on authorities to enhance oversight of online sales of drugs and crack down on price gouging.

Pfizer negotiations halt due to cost

China is yet to approve a foreign-made vaccine for the Covid virus. Instead, its regulators have opted for homegrown antiviral pills to combat the pandemic. A top health official on Wednesday said that hundreds of pills to alleviate Covid symptoms were already covered by insurance and new viral treatments were in the pipeline.

Borla claimed on Monday that negotiations ceased because China demanded a lower price than Pfizer is seeking from the majority of lower middle-income nations.

In a separate statement, Pfizer declined to comment on the price it had proposed, but stated that it was “committed to meeting the Covid-19 treatment needs of Chinese patients” and that it “will continue to collaborate with the Chinese government and all relevant stakeholders to secure an adequate supply of Paxlovid in China.”

However, for individuals who have been dealing with the immediate issues of acquiring access to medications for themselves and their families, like Wang in Beijing, there is a sense that the system isn’t functioning—at least not right now.

“It is cruel. There is nothing we can do, no matter how we feel”, she said. It is untrue that your efforts or hopes will improve the situation.

[embedpost slug=”/covid-to-peak-in-rural-china-over-new-year/”]

Read more

Menu

Latest

Entertainment

Lifestyle